InvestSMART

Vitasora Health Limited (ASX:VHL)

ALERT: Price-sensitive ASX Announcement for VHL
Current share price for VHL : $0.013 0.003 (30%)+
Announcement
Release
31 Jul 2026 8:48AM
Price at Release
$0.010
Full Release
download
Summary
Vitasora Health Limited (ASX: VHL), a leader in AI-powered connected care and chronic disease management solutions, reported its quarterly activities and Appendix 4C cash flow report for the quarter ended 30 June 2026. The company marked an important inflection point with the transition to its vCare platform, achieving its strongest fee-for-service month in June with improved billable yield. Operating expenses were reduced, and a significant increase in new patient enrolments was noted compared to the previous quarter. The financial position was strengthened by a completed placement, and the company is optimistic about future revenue growth and achieving cashflow breakeven in FY27.
Key Points
  • Vitasora Health Limited reported its quarterly activities for the quarter ended 30 June 2026.
  • The transition to the vCare platform marked a strong operational inflection point.
  • June was the strongest fee-for-service month in company history.
  • Billable yield improved to 84.5% by June.
  • The company reduced operating expenses and saw a significant increase in new patient enrolments.
  • A $4.0 million placement was completed, strengthening the balance sheet.
  • Vitasora is targeting cashflow breakeven in FY27.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.